![Recently, the man referred to as the "Dusseldorf patient" became at least the third person to have been “cured of HIV” after a bone marrow transplant carrying a specific HIV-resistant mutation Recently, the man referred to as the "Dusseldorf patient" became at least the third person to have been “cured of HIV” after a bone marrow transplant carrying a specific HIV-resistant mutation](https://vajiramandravi.s3.us-east-1.amazonaws.com/media/2023/2/24/13/8/52/CCR5_Delta_32_mutation.png)
Recently, the man referred to as the "Dusseldorf patient" became at least the third person to have been “cured of HIV” after a bone marrow transplant carrying a specific HIV-resistant mutation
![CCR5 and CCR5Δ32 in bacterial and parasitic infections: Thinking chemokine receptors outside the HIV box - Ellwanger - 2020 - International Journal of Immunogenetics - Wiley Online Library CCR5 and CCR5Δ32 in bacterial and parasitic infections: Thinking chemokine receptors outside the HIV box - Ellwanger - 2020 - International Journal of Immunogenetics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/24f2d566-ae6b-45f5-93a8-1527f3b508e7/iji12485-fig-0003-m.jpg)
CCR5 and CCR5Δ32 in bacterial and parasitic infections: Thinking chemokine receptors outside the HIV box - Ellwanger - 2020 - International Journal of Immunogenetics - Wiley Online Library
![TALENs-mediated homozygous CCR5Δ32 mutations endow CD4+ U87 cells with resistance against HIV‑1 infection TALENs-mediated homozygous CCR5Δ32 mutations endow CD4+ U87 cells with resistance against HIV‑1 infection](https://www.spandidos-publications.com/article_images/mmr/17/1/MMR-17-01-0243-g01.jpg)
TALENs-mediated homozygous CCR5Δ32 mutations endow CD4+ U87 cells with resistance against HIV‑1 infection
![Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV | Bentham Science Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV | Bentham Science](http://www.eurekaselect.com/images/graphical-abstract/chr/17/5/001.jpg)
Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV | Bentham Science
![The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV | SpringerLink The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12015-021-10145-7/MediaObjects/12015_2021_10145_Figa_HTML.png)
The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV | SpringerLink
![CCR5-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool | Cell & Bioscience | Full Text CCR5-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool | Cell & Bioscience | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13578-020-00410-6/MediaObjects/13578_2020_410_Fig1_HTML.png)
CCR5-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool | Cell & Bioscience | Full Text
![The effect of the CCR5-delta32 deletion on global gene expression considering immune response and inflammation | Journal of Inflammation | Full Text The effect of the CCR5-delta32 deletion on global gene expression considering immune response and inflammation | Journal of Inflammation | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1476-9255-8-29/MediaObjects/12950_2011_Article_209_Fig1_HTML.jpg)
The effect of the CCR5-delta32 deletion on global gene expression considering immune response and inflammation | Journal of Inflammation | Full Text
![CCR5: no longer a 'good for nothing' gene – chemokine control of West Nile virus infection: Trends in Immunology CCR5: no longer a 'good for nothing' gene – chemokine control of West Nile virus infection: Trends in Immunology](https://www.cell.com/cms/attachment/582246/4387144/gr1.jpg)
CCR5: no longer a 'good for nothing' gene – chemokine control of West Nile virus infection: Trends in Immunology
![CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo: Molecular Therapy CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo: Molecular Therapy](https://www.cell.com/cms/attachment/2119340444/2092430962/fx1.jpg)